Effect of percutaneous nephrostomy in late stage cervical cancer's survival with impaired renal function
Downloads
Objective: explore the association between percutaneous nephrostomy and survival of patients with advanced cervical cancer accompanied by renal impairment.
Materials and Methods: Retrospective cohort, with 70 samples taken with consecutive sampling. The population was all advanced cervical cancer patients with impaired renal function (IIIB, IVA, IVB, recurrent) treated in RSUPNCM since January 1, 1998. Sample size was each 19 patients for percutaneous nephrostomy and conservative groups. Survival was measured from medical records of advanced cervical cancer patients with impaired renal function who were treated at RSUPNCM since January 1, 1998 until December 31, 2003. Percutaneous nephrostomy was measured from medical records of advanced cervical cancer patients with impaired renal function treated at RSUPNCM since 1 January 1998 until December 31, 2003.
Results: Median survival of 44 respondents who underwent percutaneous nephrostomy was 203 days with probability of survival at 6 months 56.9% and 12 months by 31.1%. Median survival of 26 respondents who did not undergo percutaneous nephrostomy was 75 days with a chance of survival at 6 months 26.6% and 12 months 10%. There were significant differences between patients undergoing percutaneous nephrostomy and those without (p = 0.0470, α = 0.05).
Conclusion: There was significant association between percutaneous nephrostomy and survival (p = 0.0470, α = 0.05).
Ferlay J, et al. GLOBOCAN 2012: Estimat-ed Cancer Incidence, Mortality and Prevalence World-wide in 2012. [In a network] Available at:http:// globocan.iarc.fr/Pages/fact_sheets_cancer.aspx. 2013. Accessed 23 February 2015.
Panigoro R, et al. Linear HPV Genotyping Assay Comparison Test in Cervical Cancer Patients: Implications for HPV Prevalence and Molecular Epidemiology in a Limited-resource areas in Bandung, Indonesia. Asian Pacific Journal of Cancer Prevention. 2013;14(10):5843-47.
Rasjidi I. Survival and Prognostic Factors in Patients with Advanced Stage Cervical Cancer with Impaired Renal Function. Faculty of Medicine, University of Indonesia. 2004.
Nuranna L, et al. Management of Adcanced cervic-al al Cancer With Renal Failure. In AOFOG. Bali. 1995.
Mishra K, et al. Role of Percutaneous Nephrosto-my in Advanced Cervical Carcinoma with Obstruc-tive uropathy: A Case Series. Indian Journal of Palliative Care. 2009;15(1):37-40.
Janaki MG, Mukesh S, Ponni TRA and Nirmala S. Aggressive Approach in a Case of Cancer Cervix with Uremia. Indian Journal of Palliative Care. 2010;16(1):52-4.
Dagli M and Ramchandani P. Percutaneous Neph-rostomy: Technical Aspects and Indications. Seminars in Interventional Radiology. 2011;28(4): 424-37.
Demetriu D and Sebeikat D. Percutaneous Neph-rostomy in Malignant Ureteral Obstruction. Deutsche Medizinische Wochenschrift. 1996;121 (49):1526-30.
Ahmed I, et al. Effectiveness of Percutan-eous Nephrostomy Reversing Obstruction in Renal Failure. Journal of Pakistan Medical Association. 1995;45(1):16-8.
Gasparini M, Carroll P and Stoller M. Percutaneous and Endoscopic Palliative Urinary Diversion for Malignant Ureteral Obstruction. Urology. 1991; 38(5):408-12.
Harrington KJ, et al. Palliation of Obstructive Nephropathy due to Malignancy. British Journal of Medical and Surgical Urology. 1995;76(1):101-7.
Romero FR, et al. Indications for Percutaneous Nephrostomy in Patients with Obstructive uropathy due to Malignant urogenital neoplasias. Interna-tional Braz J Urol. 2005;31(2):117-24.
Thüroff JW and Gillitzer R. Chapter 8. Percutan-eous Endourology & Ureterorenoscopy. In JW McAninch & Lue TF, eds. Smith and Tanagho's General Urology. 8th Eds. New York: McGraw-Hill; 2013.
1. Copyright of the article is transferred to the journal, by the knowledge of the author, whilst the moral right of the publication belongs to the author.
2. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution-Non Commercial-Share alike (CC BY-NC-SA), (https://creativecommons.org/licenses/by-nc-sa/4.0/)
3. The articles published in the journal are open access and can be used for non-commercial purposes. Other than the aims mentioned above, the editorial board is not responsible for copyright violation
The manuscript authentic and copyright statement submission can be downloaded ON THIS FORM.
